Medical Services

Plasma Cell Disorders are a group of diseases characterized by the abnormal growth of plasma cells, a type of white blood cell responsible for producing antibodies that help fight infections. In these disorders, plasma cells multiply uncontrollably and produce excessive amounts of abnormal proteins known as monoclonal (M) proteins. Common plasma cell disorders include monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma, solitary plasmacytoma, and light chain amyloidosis.

Symptoms vary depending on the specific condition but may include persistent bone pain, frequent fractures, fatigue, weakness, recurrent infections, unexplained weight loss, excessive thirst, kidney dysfunction, numbness, and anemia. Some individuals with early-stage disorders, such as MGUS, may have no symptoms and are diagnosed during routine blood tests.

Diagnosis involves complete blood count (CBC), serum protein electrophoresis, immunofixation, serum free light chain assay, urine protein analysis, bone marrow biopsy, imaging studies, and kidney function tests. These investigations help determine the type and severity of the disorder.

Treatment depends on the diagnosis and disease stage. Options include careful monitoring, chemotherapy, targeted therapy, immunotherapy, corticosteroids, stem cell transplantation, radiation therapy, and supportive treatments for bone and kidney health. Early detection, regular follow-up, and personalized treatment strategies can improve outcomes, reduce complications, and enhance the quality of life for affected individuals.